Previous close | 0.0500 |
Open | 0.0500 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 1.00 |
Expiry date | 2024-07-19 |
Day's range | 0.0400 - 0.0500 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Key Takeaways; Cannabis Sector Cansortium and RIV Capital announced a merger to form a new four-state cannabis MSO. Canopy Growth reported mixed financial results amid revenue decline and strategic restructuring. Trulieve settled litigation with Harvest of Ohio, as the company aims to expand its footprint in Ohio. Goodness Growth is seeking $860 million from Verano […]
The Court concludes that Plaintiff has sufficiently demonstrated that its trade secrets derived economic value from not being readily ascertainable by othersWESTON, Fla., Jan. 11, 2024 (GLOBE NEWSWIRE) -- GBB Drink Lab. Inc (“GBB” or the “Company”), a maker of the world’s first rapid blood alcohol detoxification beverage, is pleased to announce that a federal court has refused to dismiss the Company’s ongoing lawsuit against FSD Pharma. FSD Pharma (NASDAQ: HUGE), a clinical-stage biotech company
TORONTO, August 25, 2023--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders, today provides clarity and rebuttal to frivolous claims disparaging the Company and its groundbreaking efforts relating to its development of an innovative rapid alcohol detoxification drink, using its pro